Biocytogen Pharmaceuticals H1 revenue up 51.6%
Biocytogen Pharmaceuticals reported H1 revenue up 51.6%.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.
Biocytogen Pharmaceuticals reported H1 revenue up 51.6%.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.